One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Chemed Corporation logo
Chemed Corporation CHE
$ 511.37 -1.02%
report update icon

Quarterly report 2026-Q2
added 07-31-2026

Chemed Corporation Income Statement 2025-2007 | CHE

Brief overview of revenue and earnings at Chemed Corporation

The comparison covers a five-year financial horizon. The revenue attributed to Chemed Corporation moved from $1.9 billion to $2.4 billion between the two endpoints. Overall revenue changed by +25.4%, equal to an annualized rate of about 4.6%. Revenue was effectively stagnant over the period.

At the gross-profit level, the result moved from 617 million dollars to 854 million dollars, a change of +38.4%. The cost base moved more slowly than the top line, which supported margins. Gross profit as a share of revenue changed from 31.8% to 35.1%. The business retained more gross profit from each unit of revenue.

The operating result measured by EBITDA moved from $312 million to $430 million, or +37.8%. The operating result outpaced sales and points to improving efficiency. Comparing the endpoints gives EBITDA margins of 16.1% and 17.7%. The operating margin showed no pronounced shift.

The five-year change in net income was +37.3%: from 220 million dollars to 302 million dollars. Profit outpaced sales and strengthened the quality of growth.

Market capitalization changed from $7.7 billion to $9 billion (+16.5%). The market broadly confirmed the positive direction of the business.

Financial takeaway

The figures do not all move in the same direction. The financial profile benefits from better sales economics, net-income growth and higher operating efficiency. The most visible risks are weak sales momentum. Investors should continue to monitor margins, costs, and earnings quality.

Annual Income Statement Chemed Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Market Cap

8.21 B 8.97 B 9.41 B 8.01 B 7.34 B 8.23 B 7.7 B 4.76 B 4.26 B 2.7 B 2.37 B 1.74 B 1.45 B 1.43 B 1.16 B 1.26 B 885 M 832 M -

Shares

14.4 M 15 M 15 M 14.9 M 15.7 M 16 M 16 M 16.1 M 16.1 M 16.4 M 16.9 M 17.2 M 18.2 M 18.9 M 20.5 M 22.6 M 22.5 M 23.1 M -

Historical Prices

570 597 626 536 468 516 464 295 257 162 136 97.5 75.3 71.4 52.4 56 39.4 36.1 67.4

Net Income

265 K 302 K 273 K 250 K 269 M 319 M 220 M 206 M 98.2 M 109 M 110 M 99.3 M 77.2 M 89.3 M 86 M 81.8 M 73.8 M 67.3 M -

Revenue

2.53 B 2.43 B 2.26 B 2.13 B 2.14 B 2.08 B 1.94 B 1.78 B 1.67 B 1.58 B 1.54 B 1.46 B 1.41 B 1.43 B 1.36 B - - - -

Cost of Revenue

1.71 B 1.58 B 1.47 B 1.37 B 1.37 B 1.38 B 1.32 B 1.23 B 1.15 B 1.12 B 1.09 B 1.03 B 1.01 B 1.03 B 970 M 906 M 835 M 811 M -

Gross Profit

- - - - - - 617 M 554 M 516 M 461 M 456 M 422 M 405 M 397 M 385 M - - - -

Operating Income

338 M 366 M 341 M 343 M 343 M 390 M 257 M 244 M 113 M 179 M 184 M 168 M 133 M 156 M 154 M 144 M 126 M 133 M -

Interest Expense

1.75 M 1.78 M 3.11 M 4.58 M 1.87 M 2.36 M 4.54 M 4.99 M 4.27 M 3.72 M 3.64 M 8.19 M 15 M 14.7 M 13.9 M 12 M 11.6 M 12.1 M -

EBITDA

403 M 430 M 401 M 403 M 402 M 446 M 312 M 284 M 240 M 213 M 218 M 201 M 192 M 187 M 183 M 168 M 148 M 154 M -

Operating Expenses

2.19 B 2.06 B 1.92 B 1.79 B - - 351 M 309 M 312 M 283 M 271 M 253 M 245 M 240 M 232 M - - - -

General and Administrative Expenses

417 M 424 M 395 M 359 M 367 M 330 M 306 M 270 M 277 M 244 M 238 M 220 M 213 M 209 M 202 M 202 M 197 M 175 M -

All numbers in USD currency

Quarterly Income Statement Chemed Corporation

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2

Shares

13.2 M 13.7 M 14.4 M 14.6 M 14.6 M 15 M 15.1 M 15.1 M 15.1 M 15.1 M 15 M - 14.9 M 14.9 M 15 M - 15.6 M 15.8 M 16 M - 15.9 M 15.9 M 16 M - 16 M 15.9 M 16 M - 16.1 M 16 M 16.1 M - 16 M 16 M 16.2 M - 16.2 M 16.4 M 16.7 M - 16.9 M 16.9 M 16.9 M - 17 M 17.2 M 17.5 M - 18.2 M 18.6 M 18.5 M - 19 M 19 M 19 M - 20.7 M 21.1 M 21.1 M 22.6 M 22.6 M

Net Income

67.7 M 66.3 M 64.2 M 52.5 M 71.8 M 75.8 M 70.9 M 65 M 75 M 53.4 M 54.1 M - 56.9 M 66.5 M 64.2 M - 72 M 56.5 M 65.4 M - 67.7 M 82.1 M 55.9 M - 58.9 M 50.7 M 44.7 M - 51.2 M 55 M 45 M - 35.4 M -21.7 M 29.8 M - 26.8 M 24.9 M 24.8 M - 28.8 M 27 M 24.5 M - 24.6 M 24.4 M 20.6 M - 17.4 M 14.6 M 22.3 M - 20.8 M 21.3 M 20.4 M - 21.9 M 20.3 M 18.1 M 21 M 18.9 M

Revenue

673 M 658 M 625 M 619 M 647 M 606 M 596 M 589 M 565 M 554 M 560 M - 526 M 531 M 531 M - 539 M 532 M 527 M - 528 M 502 M 516 M - 481 M 474 M 462 M - 444 M 442 M 439 M - 417 M 415 M 406 M - 393 M 390 M 390 M - 386 M 382 M 377 M - 358 M 360 M 358 M - 341 M 357 M 367 M - 354 M 354 M 353 M - 341 M 333 M 331 M - -

Cost of Revenue

452 M 442 M 428 M 434 M 431 M 396 M 390 M 385 M 362 M 374 M 371 M - 347 M 337 M 337 M - 342 M 350 M 340 M - 339 M 352 M 352 M - 328 M 324 M 322 M - 305 M 306 M 305 M - 288 M 286 M 285 M - 282 M 276 M 278 M - 272 M 271 M 269 M - 256 M 257 M 258 M - 243 M 255 M 264 M - 257 M 257 M 257 M - 245 M 240 M 237 M 228 M 224 M

Operating Income

89.2 M 84.6 M 74.8 M 68.1 M 94.8 M 92.2 M 88.1 M 72.3 M 86.8 M 69.5 M 72.8 M - 80.9 M 91.9 M 89.4 M - 92.9 M 71.7 M 80.4 M - 74.3 M 92.8 M 79.4 M - 64.9 M 65.5 M 49.5 M - 61.7 M 58.1 M 56.4 M - 54 M -38.9 M 41.5 M - 42.9 M 38.4 M 44.4 M - 50.1 M 44.6 M 40.6 M - 40.2 M 41.5 M 36.7 M - 29.2 M 25.9 M 38.9 M - 36 M 39.5 M 35 M - 41.3 M 35.8 M 30.5 M 36.8 M 33.9 M

Interest Expense

1.79 M 512 K 457 K 443 K 329 K 427 K 429 K 425 K 444 K 771 K 1.55 M - 1.27 M 902 K 810 K - 583 K 379 K 381 K - 379 K 651 K 975 K - 1.04 M 1.24 M 1.12 M - 1.08 M 1.52 M 1.21 M - 1.05 M 1.12 M 995 K - 1.02 M 971 K 842 K - 908 K 969 K 969 K - 980 K 2.43 M 3.82 M - 3.5 M 3.7 M 4.09 M - 3.74 M 3.67 M 3.62 M - 3.56 M 3.46 M 3.24 M 3 M 3 M

EBITDA

123 M 101 M 88.4 M 81.8 M 111 M 105 M 101 M 88.1 M 99.7 M 82.1 M 87.6 M - 93 M 105 M 104 M - 138 M 85.3 M 94.7 M - 117 M 121 M 93.2 M - 96 M 86 M 59.7 M - 90.5 M 77.2 M 65.7 M - 80.7 M -21.1 M 50.4 M - 68.8 M 55.6 M 52.9 M - 74.7 M 61 M 48.7 M - 64.5 M 57.7 M 43.8 M - 36.2 M 32.8 M 45.6 M - 42.5 M 45.9 M 41.2 M - 47.6 M 42.2 M 36.8 M 43.1 M 40 M

Operating Expenses

584 M 573 M 550 M 551 M 552 M 514 M 508 M 517 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

115 M 114 M 106 M 100 M 106 M 102 M 102 M 116 M 99.6 M 95 M 100 M - 84 M 87.9 M 90 M - 89.2 M 93.8 M 91.6 M - 88.3 M 84.5 M 70.6 M - 76.8 M 71.6 M 74 M - 67.2 M 68.3 M 69 M - 66.9 M 68.7 M 69.5 M - 59.4 M 62.6 M 59 M - 55.8 M 58.4 M 59 M - 53.6 M 53.6 M 55.7 M - 48.9 M 53.1 M 55.6 M - 53 M 49.8 M 53.2 M - 47.6 M 50.4 M 55.7 M 48.2 M 50 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Chemed Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Care facilities industry

Issuer Price % 24h Market Cap Country
Community Health Systems Community Health Systems
CYH
$ 2.82 -1.05 % $ 377 M usaUSA
Surgery Partners Surgery Partners
SGRY
$ 15.4 -0.58 % $ 1.96 B usaUSA
Sanara MedTech Sanara MedTech
SMTI
$ 32.77 -1.12 % $ 283 M usaUSA
HCA Healthcare HCA Healthcare
HCA
$ 459.4 -1.36 % $ 109 B usaUSA
Tenet Healthcare Corporation Tenet Healthcare Corporation
THC
$ 269.13 -1.17 % $ 24.3 B usaUSA
Universal Health Services Universal Health Services
UHS
$ 182.87 -1.48 % $ 11.6 B usaUSA
Addus HomeCare Corporation Addus HomeCare Corporation
ADUS
$ 117.95 -0.07 % $ 2.13 B usaUSA
The Ensign Group The Ensign Group
ENSG
$ 173.35 -1.51 % $ 9.93 B usaUSA
Healthcare Services Group Healthcare Services Group
HCSG
$ 21.71 0.98 % $ 1.57 B usaUSA
DaVita DaVita
DVA
$ 176.81 0.83 % $ 13.1 B usaUSA
MEDNAX MEDNAX
MD
$ 28.1 0.07 % $ 2.36 B usaUSA
The Pennant Group The Pennant Group
PNTG
$ 41.04 -1.06 % $ 1.42 B usaUSA
U.S. Physical Therapy U.S. Physical Therapy
USPH
$ 86.28 -0.85 % $ 1.31 B usaUSA
Brookdale Senior Living Brookdale Senior Living
BKD
$ 10.08 0.1 % $ 2.37 B usaUSA
Capital Senior Living Corporation Capital Senior Living Corporation
CSU
- -2.09 % $ 216 M usaUSA
New Frontier Health Corporation New Frontier Health Corporation
NFH
- 3.54 % $ 1.5 B usaUSA
The Joint Corp. The Joint Corp.
JYNT
$ 7.17 -0.28 % $ 109 M usaUSA
Aesthetic Medical International Holdings Group Limited Aesthetic Medical International Holdings Group Limited
AIH
- 10.96 % $ 46.2 M chinaChina
Five Star Senior Living Inc. Five Star Senior Living Inc.
FVE
- -0.32 % $ 98.4 M usaUSA
Genesis Healthcare, Inc. Genesis Healthcare, Inc.
GEN
- - $ 68.1 M usaUSA
Avalon GloboCare Corp. Avalon GloboCare Corp.
AVCO
- 26.45 % $ 70.6 M usaUSA
Apollo Medical Holdings Apollo Medical Holdings
AMEH
- -2.11 % $ 1.84 B usaUSA
Regional Health Properties Regional Health Properties
RHE
- - $ 5.2 M usaUSA
Select Medical Holdings Corporation Select Medical Holdings Corporation
SEM
- - $ 2.02 B usaUSA
Мать и Дитя Мать и Дитя
MDMG
- - - russiaRussia
ЮМГ ЮМГ
GEMC
- - - russiaRussia
IMAC Holdings IMAC Holdings
IMAC
- -1.77 % $ 25.4 M usaUSA
ModivCare ModivCare
MODV
- -25.23 % $ 6.12 M usaUSA
National HealthCare Corporation National HealthCare Corporation
NHC
$ 235.6 -4.79 % $ 3.65 B usaUSA
Phibro Animal Health Corporation Phibro Animal Health Corporation
PAHC
$ 39.25 1.16 % $ 1.59 B usaUSA
American Shared Hospital Services American Shared Hospital Services
AMS
$ 1.25 -2.34 % $ 8.27 M usaUSA
AMN Healthcare Services AMN Healthcare Services
AMN
$ 43.01 3.49 % $ 1.66 B usaUSA
Acadia Healthcare Company Acadia Healthcare Company
ACHC
$ 31.43 0.14 % $ 2.85 B usaUSA
Concord Medical Services Holdings Limited Concord Medical Services Holdings Limited
CCM
$ 3.68 -14.02 % $ 482 M chinaChina
Encompass Health Corporation Encompass Health Corporation
EHC
$ 120.47 -0.99 % $ 12.1 B usaUSA
Elanco Animal Health Incorporated Elanco Animal Health Incorporated
ELAN
$ 22.55 -0.66 % $ 11.2 B usaUSA
Oak Street Health Oak Street Health
OSH
- 0.03 % $ 9.53 B usaUSA
Ontrak Ontrak
OTRK
- -11.98 % $ 1.53 M usaUSA
Amedisys Amedisys
AMED
- 0.01 % $ 3.3 B usaUSA
Tivity Health Tivity Health
TVTY
- 0.09 % $ 1.6 B usaUSA
SunLink Health Systems SunLink Health Systems
SSY
- 17.98 % $ 7.81 M usaUSA
LHC Group LHC Group
LHCG
- - $ 5.27 B usaUSA
Hanger Hanger
HNGR
- - $ 732 M usaUSA
Novo Integrated Sciences Novo Integrated Sciences
NVOS
- -13.87 % $ 1.52 M usaUSA
Fresenius Medical Care AG & Co. KGaA Fresenius Medical Care AG & Co. KGaA
FMS
$ 21.56 0.7 % $ 6.28 B germanyGermany
Option Care Health Option Care Health
OPCH
$ 31.29 -0.22 % $ 5.07 B usaUSA
COMPASS Pathways plc COMPASS Pathways plc
CMPS
$ 11.84 -0.5 % $ 1.11 B britainBritain